Research & development > Clinical diagnostics

POC infection diagnosis combats antibiotic resistance

11 March, 2020

A new infection test, made up of sheets of paper patterned by lasers, will enable diagnosis at the point of care — helping doctors give patients the right treatment, and quickly.


Gold nanoparticles used to detect cancer

04 March, 2020

The nanotechnology developed by University of Queensland scientists can detect and monitor extracellular vesicles (EVs) in the bloodstream.


Chest CT scans recommended for COVID‑19 screening

02 March, 2020

Computed tomography (CT) of the chest demonstrates better sensitivity than reverse-transcription polymerase chain reaction (RT‑PCR) when it comes to diagnosing COVID‑19.


Rapid diagnostic test for Ebola under development

26 February, 2020

The test will detect the infection early in blood by embedding monoclonal antibodies against surface glycoproteins (GP) — one of the first detectable biomarkers of infection.


Saliva test offers easier detection of mouth and throat cancer

13 January, 2020

A novel non-invasive technique can successfully detect human papilloma virus-16 — the strain associated with oropharyngeal cancer — in saliva samples.


Rapid asthma diagnosis with a drop of blood

12 December, 2019

A new rapid test is expected to return a finding after just 60 to 90 min — and all it requires to diagnose asthma is a drop of blood and the immune cells it contains.


Home urine test helps diagnose aggressive prostate cancer

11 December, 2019

The urine test diagnoses aggressive prostate cancer and predicts whether patients will require treatment up to five years earlier than standard clinical methods.


Blood test could detect deadly eye melanoma

26 November, 2019

Scientists have discovered markers in the blood that can differentiate between a benign mole and a melanoma in the eye, while also identifying if the cancer has spread.


Three new methods for early cancer detection

14 November, 2019

The UK's National Cancer Research Institute has announced several promising new methods for detecting cancer early, as detailed at the 2019 NCRI Cancer Conference.


Blood test enables rapid TB diagnosis

05 November, 2019

The test procedure is hoped to positively impact tuberculosis diagnosis in adults living in remote areas.


Blood test to detect multiple types of cancer

10 October, 2019

In contrast to liquid biopsies, which detect genetic mutations or other cancer-related alterations in DNA, the technology focuses on modifications to DNA known as methyl groups.


Blood test set to reduce late detection of lung cancer

01 October, 2019

Oncimmune's EarlyCDT Lung test has been found to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.


Stamping out invasive biopsies

27 September, 2019

Researchers have developed a novel technology that could sensitively detect and classify cancer cells, as well as determine disease aggressiveness, from the least invasive biopsies.


New blood test for prostate cancer avoids false positives

19 September, 2019

By measuring intact living cancer cells in the patient's blood, rather than the PSA protein, the method potentially provides a more accurate test for prostate cancer.


Eye-tracking tests could predict Alzheimer's development

09 September, 2019

Eye-tracking technology could be used in future to predict if people with mild memory and thinking impairments will go on to develop Alzheimer's disease.


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd